News & Events

Bharat Parenterals Limited is excited to announce its participation in CPHI Worldwide 2025, scheduled for October 26–28, 2025, in Frankfurt, Germany. As one of the largest and most influential pharmaceutical exhibitions globally, ... CPHI offers an unparalleled platform for industry leaders, innovators, and decision-makers to connect and collaborate. At this prestigious event, Bharat Parenterals will showcase facets of its fully integrated company with a focus on emerging markets and unwavering commitment to delivering quality-driven healthcare solutions. We look forward to engaging with international partners, exploring new opportunities for collaboration, and strengthening our footprint in the global pharmaceutical arena. Visit our booth to meet our expert team and discover how Bharat Parenterals Limited is driving excellence and innovation in the pharma industry. Read more

Bharat Parenterals Limited is proud to announce that our Managing Director, Mr. Bharat Desai, has been honoured with the prestigious HSBC presents CNBC-TV18 SME Champion Award Season-2 under the category of Manufacturing SME of the Year – Health & Pharma. This award recognizes outstanding performance, innovation, and impact in the Indian SME sector, particularly in the pharmaceutical manufacturing space. ... This national-level recognition is a testament to our unwavering commitment to quality, excellence, and ethical growth in the healthcare sector. It not only celebrates the visionary leadership of Mr. Bharat Desai but also highlights the dedication of the entire Bharat Parenterals team in delivering world-class pharmaceutical products. We thank our stakeholders, partners, and employees for being an integral part of this journey. Read more

The Subsidiary Company of Bharat Parenterals Limited Namely, Innoxel Lifesciences Pvt. Ltd., has received the Establishment Inspection Report (EIR) from the United States Food and Drug Administration (U.S. FDA) for its finished dosage manufacturing facility in Vadodara, Gujarat. ... Company has successfully cleared United States Food and Drug Administration (U.S. FDA) inspection which was conducted between April 28, 2025 to May 2, 2025 at its manufacturing facility in Vadodara, Gujarat. View PDF Read more

Bharat Parenterals Limited is proud to announce that the company has been honoured with the CSR Rural Development & Infrastructure Award for 2023-2024. This prestigious award recognizes our dedicated efforts in driving sustainable rural development and improving infrastructure in the communities we serve. Our initiatives focus on uplifting rural livelihoods through healthcare, education, and essential infrastructure projects. ... The award reflects Bharat Parenterals’ commitment to corporate social responsibility and inclusive growth. We remain devoted to making a positive and lasting impact beyond business, empowering rural areas with resources and support that foster progress and well-being. We thank our partners and team members for their unwavering dedication in helping us achieve this milestone. Read more

Bharat Parenterals Limited is honoured to receive the Resilient Award from the Southern Gujarat Chamber of Commerce & Industry, in association with the Gujarat Pollution Control Board (GPCB). This esteemed recognition was presented during the Environment Conclave 2025 CER Award Ceremony, celebrating our company’s outstanding contribution in the category of Air Quality Management. The award acknowledges our ongoing commitment to sustainable practices and environmental responsibility within the pharmaceutical manufacturing sector. ... At Bharat Parenterals, we believe that caring for the environment goes hand-in-hand with our mission to provide quality healthcare solutions. This recognition motivates us to continue implementing innovative and eco-friendly processes that help improve air quality and reduce environmental impact. We extend our gratitude to the organizers and pledge to uphold our responsibility towards a cleaner and healthier environment. Read more

Bharat Parenterals Limited is pleased to announce the successful completion of the Paraguay Audit in April of 2025. This important milestone underscores our commitment to maintaining the highest standards of quality, compliance, and regulatory excellence in international markets. The audit evaluated our manufacturing processes, quality control systems, and operational practices, all of which met the stringent requirements set by Paraguayan authorities. ... Clearing this audit not only strengthens our global footprint but also reinforces the trust of our international partners and customers. Bharat Parenterals continues to uphold its promise of delivering safe, effective, and reliable pharmaceutical products worldwide, while adhering to global best practices and regulatory frameworks. Read more

Bharat Parenterals Limited proudly participated in the Arab Pharma Manufacturers Expo 2024, held in Dubai from January 27–30, 2025. The event brought together key players from the pharmaceutical manufacturing sector across the Middle East, North Africa, and Asia, offering a dynamic platform for global networking and business development. ... During the expo, our team engaged with potential partners, showcased our advanced manufacturing capabilities, and discussed opportunities for expansion into emerging markets. The event highlighted our ongoing commitment to delivering quality pharmaceutical solutions worldwide. We extend our sincere thanks to all the delegates and visitors who connected with us in Dubai. Read more